OakChart

Establishment Labs Holdings Inc

ESTAHealthcare·Medical Devices·USA·Mid·NASD·Nov 11 • 11:57 AM ET

70.81+3.58 (5.32%)
2026-11-11 17:58 CET
Market cap
2,003.58 USD m
Revenue, TTM
264.03 USD m
Net income, TTM
-38.45 USD m
Free cash flow, TTM
-22.57 USD m
EPS diluted, TTM
-1.28
P/E
-
Compare

Price

ESTA against its 20, 50 and 200-day averages
2050200miss
60.0070.0080.0090.00100.002.6M5.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ESTAclose 70.8120-day 64.4750-day 66.20200-day 72.3870.8152w high52w low

27.4% under the 52-week high of 97.59 on 3 Aug 2026. 52-week low 53.16 on 31 Mar 2026. Last 15 sessions, 19.3% high to low

Profile

ESTA
52-week range, 40% of the way up
53.1697.59

Establishment Labs Holdings, Inc. engages in the manufacturing and marketing of medical devices for aesthetic and reconstructive plastic surgery. Its brands include Motiva Implants, SilkSurface, SmoothSilk, VelvetSurface, ProgressiveGel, TrueMonobloc, BluSeal, Divina, Ergonomix, Ergomonix2, Ergonomix2 Diamond, Mia Femtech, MotivaImagine, GEM, Zen, Preserve, etc. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Austin, TX.

IndexRUT
Employees1004
IPOJul 19, 2018
Beta0.99
ATR, 14d4.22
Rel volume0.55
Short float14.35%
Insider own8.39%
Inst own101.48%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.11B
Enterprise Value2.31B
Income-38.45M
Sales264.03M
Book/sh0.52
Cash/sh2.54
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1004
IPOJul 19, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S8.00
P/B135.41
P/C27.86
P/FCF-
EV/EBITDA-
EV/Sales8.73
Quick Ratio2.38
Current Ratio3.57
Debt/Eq17.29
LT Debt/Eq17.29
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.28
EPS next Y-0.11
EPS next Q-0.19
EPS this Y19.93%
EPS next Y91.86%
EPS next 5Y-
EPS past 3/5Y17.54% -1.07%
Sales past 3/5Y9.29% 20.04%
EPS Y/Y TTM55.14%
Sales Y/Y TTM38.25%
EPS Q/Q6.48%
Sales Q/Q33.86%
EarningsOct 29 BMO
EPS/Sales Surpr.-36.29% 7.75%

Ownership

Insider Own8.39%
Insider Trans-4.25%
Inst Own101.48%
Inst Trans7.22%
ROA-11.02%
ROE-240.66%
ROIC-13.49%
Gross Margin70.18%
Oper. Margin-6.57%
Profit Margin-14.56%
SMA209.83%
SMA506.97%
SMA200-2.16%
Trades-

Technical

Shs Outstand29.82M
Shs Float27.30M
Short Float14.35%
Short Ratio9.28
Short Interest3.92M
52W High97.59 -27.44%
52W Low53.16 33.21%
Volatility7.72% 6.66%
ATR (14)4.22
RSI (14)59.80
Beta0.99
Rel Volume0.55
Avg Volume422.22K
Volume93,908

Performance

Perf Week5.78%
Perf Month21.15%
Perf Quarter-6.32%
Perf Half Y2.50%
Perf YTD-2.84%
Perf Year3.45%
Perf 3Y226.61%
Perf 5Y2.15%
Perf 10Y-
Recom1.00
Target Price98.00
Prev Close67.23
Price70.81
Change %5.32%

Analyst ratings

latest 10 of 17
DateActionAnalystRating changeTargetImplied
Oct 15, 2026InitiatedSStifelBuy$85+20.0%
Aug 13, 2026UpgradeCCitigroupNeutral → Buy$92+29.9%
Aug 20, 2025InitiatedCCanaccord GenuityBuy$60-15.3%
May 16, 2025InitiatedBBTIG ResearchBuy$62-12.4%
May 14, 2025UpgradeNNeedhamHold → Buy$48-32.2%
Apr 14, 2025InitiatedNNeedhamHold
May 22, 2024DowngradeCCitigroupBuy → Neutral$60-15.3%
Aug 31, 2023InitiatedJJP MorganOverweight$75+5.9%
Jun 29, 2023InitiatedCCitigroupBuy$79+11.6%
Oct 14, 2022ResumedSStephensOverweight$90+27.1%

Peers

Mkt cap
TickerCompanyMkt cap
ABBVAbbvie Inc513.88B
INMDInmode Ltd772.24M
APYXApyx Medical Corp123.42M
JNJJohnson & Johnson668.63B
EOLSEvolus Inc473.91M
TELATELA Bio Inc37.08M
RCELAVITA Medical Inc430.35M
BHCBausch Health Companies Inc3.12B
AIRSAirsculpt Technologies Inc64.31M
SKINSkinHealth Systems Inc102.75M

Insider trading

latest 14 of 17
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JUAN JOSE CHACON QUIROSDirectorJun 15 '26Proposed Sale83.7924,1982,027,550Jun 15 04:49 PM
JW Asset Management, LLCMay 28 '26Sale72.8965,1004,745,1392,890,582May 28 08:49 PM
JW Asset Management, LLCMay 26 '26Sale74.3925,3201,883,5552,955,795May 28 08:49 PM
JW Asset Management, LLCMay 27 '26Sale72.501138,1922,955,682May 28 08:49 PM
JW Asset Management, LLC10% OwnerMay 21 '26Sale71.4016,9991,213,7292,981,115May 22 05:46 PM
JW Asset Management, LLC10% OwnerMay 20 '26Sale70.563,580252,6052,998,114May 22 05:46 PM
Chacon Quiros Juan JoseDirectorMay 06 '26Sale75.42105,0007,918,872927,504May 08 04:09 PM
JW Asset Management, LLC10% OwnerMay 06 '26Sale75.6260,0004,537,5003,001,694May 08 04:03 PM
Chacon Quiros Juan JoseDirectorMay 01 '26Sale70.7867,2494,759,5691,040,255May 04 06:27 PM
Chacon Quiros Juan JoseDirectorMay 04 '26Sale70.487,751546,3081,032,504May 04 06:27 PM
Chacon Quiros Juan JoseDirectorApr 23 '26Sale65.4342,6422,790,0701,139,862Apr 27 05:38 PM
Chacon Quiros Juan JoseDirectorApr 24 '26Sale65.7830,1781,984,9691,109,684Apr 27 05:38 PM
Chacon Quiros Juan JoseDirectorApr 27 '26Sale66.262,180144,4391,107,504Apr 27 05:38 PM
Chacon Quiros Juan JoseDirectorApr 14 '26Sale65.2337,5002,446,0501,182,504Apr 16 04:05 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
TMSLT. Rowe Price Small-Mid Cap ETFAUM: 3.28B
PINKSimplify Health Care ETFAUM: 350.61M
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
VHTVanguard Health Care ETFAUM: 21.51B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
FYXFirst Trust Small Cap Core AlphaDEX FundAUM: 1.39B
ESMLiShares ESG Aware MSCI USA Small-Cap ETFAUM: 2.76B

News

latest 14 of 206
  • Establishment Labs Misses On EPS But Delivers First Positive Free Cash Flow And A Third Straight Revenue Guidance Raise (Earnings Whispers)
  • Establishment Labs Reports Third Quarter 2026 Financial Results (Business Wire)
  • Establishment Labs Faces A Seasonal Test Of Its US Boom After A 32% Slide (Earnings Whispers)
  • Establishment Labs to Announce Third Quarter 2026 Financial Results on October 29 (Business Wire)
  • Establishment Labs Receives FDA Approval for Additional Sizes of Motiva Implants (Business Wire)
  • Loading…
  • Establishment Labs Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants (Business Wire)
  • Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. (MarketWatch)
  • A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture (PR Newswire)
  • Establishment Labs Holdings Inc (ESTA) (Q2 2026) Earnings Call Highlights: U.S. Sales Surge 140. ... (GuruFocus.com) -13.37%
  • Establishment Labs Reports Second Quarter 2026 Financial Results (Business Wire)
  • Establishment Labs to Announce Second Quarter 2026 Financial Results on August 6 (Business Wire)
  • Establishment Labs Appoints Taylor Harris to Board of Directors (Business Wire)
  • Establishment Labs Added to Membership of U.S. Small-Cap Russell 2000 Index (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.350-0.257-0.35071.9966.8110
2026Q22026-08-06-0.390-0.337-0.39067.5465.799
2026Q12026-05-06-0.450-0.355-0.44759.8857.409
2025Q42026-02-24-0.090-0.222-0.08864.6263.839
2025Q32025-11-05-0.380-0.506-0.37653.7852.209
2025Q22025-08-07-0.570-0.532-0.57451.3050.968
2025Q12025-05-07-0.700-0.807-0.70341.3841.038
2024Q42025-02-26-1.190-0.639-1.19344.5144.467
2024Q32024-11-07-0.590-0.615-0.59140.2340.456
2024Q22024-08-06-0.620-0.513-0.61644.1243.107
2024Q12024-05-08-0.580-0.668-0.58337.2035.617
2023Q42024-02-28-0.790-0.912-0.78831.5631.447
2023Q32023-11-07-1.120-0.802-1.12438.5140.487
2023Q22023-08-08-0.650-0.716-0.65448.5647.366
2023Q12023-05-08-0.480-0.680-0.48446.5245.456
2022Q42023-02-27-0.550-0.678-0.55643.8143.266

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.860-2.177-1.85789.5787.52
2020FY-1.630-1.556-1.63584.6882.92
2021FY-1.720-1.424-1.716126.68126.3
2022FY-3.080-3.211-3.075161.7160.94
2023FY-3.070-3.172-3.067165.15164.94
2024FY-3.000-2.423-3.004166.03165.97
2025FY-1.720-1.864-1.720211.08210.35
2026FY--1.377--274.8
2027FY--0.112--342.91
2028FY-0.978--423.47
2029FY-1.695--525.15
2030FY-2.530--651.7

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-29102775.3374.6077.56
2026Q4S2026-10-21100076.0574.6677.00
2026Q4S2026-10-20100176.0574.6677.00
2026Q4S2026-10-13101176.0574.6677.00
2026Q4S2026-10-1291176.0074.6677.00
2026Q4S2026-10-0991175.9974.6677.00
2026Q4S2026-10-0291176.0074.6677.00
2026Q4S2026-09-0391175.9974.6677.00
2026Q4S2026-08-3191175.9974.6677.00
2026Q4S2026-08-2891175.9974.6677.00
2026Q4S2026-08-2091175.9974.6677.00
2026Q4S2026-08-0791176.0074.6677.00
2026Q4S2026-08-0691076.2174.6677.67
2026Q4S2026-07-2890075.9374.2077.67

Estimate history

EPS, annual-1.833-1.216-1.857-1.635-1.716-3.075-3.067-3.004-1.724-1.2765
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.591-1.193-0.703-0.574-0.376-0.088-0.447-0.39-0.352
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual34.68161.20889.56584.676126.682161.7165.151166.025211.076264.03
Period201720182019202020212022202320242025TTM
Sales, quarterly40.22744.51441.37751.353.78264.61759.87767.54271.993
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual19.04420.26420.64923.51824.0824.40826.08728.78729.30529.821
Period201720182019202020212022202320242025MRQ
Shares, quarterly27.96428.78728.90828.9729.05629.30529.38529.79329.821
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue264.03211.08166.03165.15161.70126.6884.6889.5661.21
Cost of Goods Sold Incl. D&A78.7464.7756.5058.1755.1141.2832.1734.7025.09
Gross Profit185.29146.31109.53106.98106.5985.4052.5054.8636.12
Selling, General and Administrative Excl. Other202.65185.32159.51172.00146.25110.5480.4285.8059.98
Research and Development20.0820.2519.7126.4320.2718.3213.7914.9912.69
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-17.35-39.01-49.99-65.03-39.66-25.14-27.92-30.94-23.86
Interest Expense28.1825.2620.8315.3911.769.069.378.708.81
Unusual Expense0.000.540.000.0018.32-0.74-1.94-3.33-14.17
Net Income Before Taxes-46.85-58.02-84.63-78.58-72.82-39.71-38.02-37.51-20.88
Income Taxes-8.39-6.96-0.03-0.082.391.430.100.640.22
Consolidated Net Income-38.45-51.06-84.60-78.50-75.21-41.14-38.12-38.15-21.10
Net Income From Continuing Operations-38.45-51.06-84.60-78.50-75.21-41.14-38.12-38.15-21.10
Net Income-38.45-51.06-84.60-78.50-75.21-41.14-38.12-38.15-21.10
EPS (Recurring)-1.26-1.71-3.00-3.07-2.55-1.74-1.69-1.97-1.79
EPS (Basic, Before Extraordinaries)-1.28-1.72-3.00-3.07-3.08-1.72-1.64-1.86-1.22
EPS (Diluted)-1.28-1.72-3.00-3.07-3.08-1.72-1.64-1.86-1.22
EBITDA-6.12-28.53-42.41-60.14-35.49-21.03-24.25-27.64-21.06
Non-Operating Income (Expense)-1.326.79-13.811.84-3.09-6.25-2.66-1.20-2.37
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.329.0211.3811.359.357.284.004.575.12
Price To Sales Ratio7.4010.237.814.019.9312.7910.366.347.77
Gross Margin70.1869.3265.9764.7865.9267.4262.0061.2559.01
Operating Margin-6.57-18.48-30.11-39.37-24.53-19.84-32.97-34.55-38.99
Net Margin-14.56-24.19-50.95-47.53-46.51-32.47-45.02-42.59-34.47
Shares Outstanding29.8229.3028.7926.0924.4124.0823.5220.6520.26
Market Capitalization2,003.582,003.581,188.99667.331,598.071,622.41882.21569.82561.31

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue71.9967.5459.8864.6253.7851.3041.3844.51
Cost of Goods Sold Incl. D&A22.2819.8317.5419.0916.0916.0313.5714.02
Gross Profit49.7147.7142.3445.5337.7035.2727.8130.49
Selling, General and Administrative Excl. Other52.3452.0048.8549.4641.7249.3844.7549.16
Research and Development4.315.105.245.434.565.205.065.14
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.62-4.29-6.51-3.93-4.03-14.11-16.95-18.67
Interest Expense6.817.037.097.246.205.965.855.95
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-10.10-11.74-13.09-11.91-10.72-15.59-19.80-35.94
Income Taxes0.610.010.29-9.300.421.000.91-1.41
Consolidated Net Income-10.71-11.75-13.38-2.62-11.15-16.59-20.71-34.53
Net Income From Continuing Operations-10.71-11.75-13.38-2.62-11.15-16.59-20.71-34.53
Net Income-10.71-11.75-13.38-2.62-11.15-16.59-20.71-34.53
EPS (Recurring)-0.35-0.39-0.45-0.09-0.38-0.57-0.70-1.19
EPS (Basic, Before Extraordinaries)-0.35-0.39-0.45-0.09-0.38-0.57-0.70-1.19
EPS (Diluted)-0.35-0.39-0.45-0.09-0.38-0.57-0.70-1.19
EBITDA0.05-1.19-3.82-1.16-1.58-11.51-14.38-16.28
Non-Operating Income (Expense)-0.67-0.420.51-0.74-0.494.473.00-11.32
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.252.402.372.292.292.521.922.80
Price To Sales Ratio7.4010.517.4110.296.366.967.078.03
Gross Margin69.0570.6470.7070.4670.0968.7667.2168.50
Operating Margin-3.64-6.35-10.87-6.08-7.48-27.50-40.96-41.94
Net Margin-14.88-17.39-22.35-4.05-20.72-32.35-50.05-77.57
Shares Outstanding29.8229.7929.3929.3029.0628.9728.9128.79
Market Capitalization2,003.582,525.421,664.842,117.741,187.511,235.061,177.051,188.99

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments75.5790.3540.0366.3653.4284.5237.6652.6410.86
Short Term Receivables77.5065.0046.9235.4224.4419.1322.7717.6513.11
Inventories86.0079.7779.9437.0228.9823.3730.5524.8413.17
Other Current Assets10.887.928.0111.116.445.284.874.302.24
Total Current Assets249.94243.04174.90149.90113.27132.3095.8499.4439.38
Net Property, Plant & Equipment79.9583.5980.5954.7920.8618.8116.4212.9113.50
Total Investments and Advances0.000.000.000.000.000.000.000.000.07
Intangible Assets10.9812.684.594.784.554.323.623.623.58
Deferred Tax Assets15.11--------
Other Assets1.187.538.571.580.850.950.660.610.56
Total Assets357.17346.83268.64211.06139.53156.39116.53116.5757.09
Short Term Debt Incl. Current Port. of LT Debt14.121.510.770.690.400.950.260.3423.70
Accounts Payable43.1144.7641.6220.0314.489.7210.376.249.13
Income Tax Payable0.380.150.11---0.00--
Other Current Liabilities24.5321.8514.6418.2417.0115.2312.629.8724.60
Total Current Liabilities82.1468.2857.1538.9631.8925.9023.2416.4557.44
Long Term Debt250.34223.78191.45178.6653.8151.7848.3522.700.60
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.141.681.651.633.103.745.337.944.07
Total Liabilities333.62293.74250.25219.2588.7981.4376.9247.0962.11
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity23.5553.1018.39-8.1950.7474.9639.6169.48-5.01
Total Shareholders Equity23.5553.1018.39-8.1950.7474.9639.6169.48-5.01
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity23.5553.1018.39-8.1950.7474.9639.6169.48-5.01
Total Liabilities & Stockholders Equity357.17346.83268.64211.06139.53156.39116.53116.5757.09
Book Value Per Share0.801.840.71-0.342.113.191.923.43-0.26
Tangible Book Value Per Share0.431.400.53-0.531.923.001.743.25-0.45
Full-Time Employees1,0041,018908958746521602505376
Price to Book Ratio128.5639.3921.911,052.0832.0811.8114.428.006.76
Return on Assets-14.51-27.49-32.73-42.90-27.80-27.94-32.73-24.30-80.54
Return on Equity-133.25-236.67-1,537.75-353.48-65.46-66.54-69.94-65.45-
Return on Invested Capital-18.64-30.55-37.41-44.12-39.35-30.08-43.37-22.89-
Quick Ratio2.002.391.662.902.644.212.814.540.46
Current Ratio3.043.563.063.853.555.114.126.050.69

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-39.82-51.06-84.60-78.50-75.21-41.14-38.12-38.15-21.10
Depreciation11.1010.477.584.884.344.123.713.292.81
Other Funds (Non Cash)30.6412.0036.1822.9440.1615.569.439.48-1.58
Funds from Operations-7.29-37.72-43.02-54.38-30.63-21.45-24.98-25.38-19.87
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-6.84-13.17-15.50-34.13-21.54-6.4412.31-4.60-14.02
Cash from Operating Activities-14.13-50.89-58.52-88.51-52.17-27.89-12.66-29.98-33.89
Capital Expenditures-10.17-6.72-15.56-24.55-34.79-7.16-5.56-7.77-1.77
Net Assets From Acquisitions-0.00-0.31-0.050.000.000.000.000.00-3.96
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00-
Purchase of Investments0.000.000.000.000.000.000.000.00-
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00-
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00-
Cash from Investing Activities-10.17-7.03-15.61-24.55-34.79-7.16-5.56-7.77-5.73
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock25.287.59101.9486.713.874.5865.10-1.4986.92
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock25.287.59101.9486.713.874.5865.10-1.4986.92
Proceedsfrom Stock Options0.000.0099.4884.540.000.0063.860.0087.63
Issuance or Reduction of Debt, Net5.5433.4824.470.0096.39-0.17-0.2824.51-5.39
Change in Long Term Debt9.0524.5024.470.0096.39-0.17-0.2824.51-0.31
Issuance of Long Term Debt272.3624.5024.470.00168.090.000.0024.750.00
Reduction of Long Term Debt-263.310.000.000.00-71.71-0.17-0.28-0.24-0.31
Net Financing Active Other Cash Flow-1.35-0.64-0.51-0.480.000.000.00-0.220.00
Other Financing Activities Uses-1.35-0.64-0.51-0.480.000.000.00-0.220.00
Cash from Financing Activities29.4840.43125.9086.23100.264.4164.8222.7981.53
Exchange Rate Effect-0.092.71-1.460.51-0.36-0.470.27-0.02-0.14
Net Change in Cash5.08-14.7850.31-26.3212.94-31.1146.87-14.9841.78
Free Cash Flow-22.57-56.94-67.04-111.73-84.94-33.17-15.09-36.27-35.62
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--9.13-2.18-3.710.090.010.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments75.8171.1668.1075.5770.6254.64
Short Term Receivables77.9275.6577.0877.5071.4470.09
Inventories85.0184.9887.0686.0088.5695.18
Other Current Assets16.9815.9413.5910.888.979.26
Total Current Assets255.72247.73245.83249.94239.60229.17
Net Property, Plant & Equipment76.6577.5178.5879.9580.7581.16
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets10.5010.6410.1710.9811.6112.40
Deferred Tax Assets---15.11--
Other Assets16.0016.0516.461.186.946.94
Total Assets358.88351.93351.04357.17338.89329.67
Short Term Debt Incl. Current Port. of LT Debt0.000.0012.9614.1211.726.62
Accounts Payable36.7432.8441.8143.1139.7255.81
Income Tax Payable--0.310.380.300.25
Other Current Liabilities34.8731.7228.0724.5320.2418.06
Total Current Liabilities71.6164.5683.1582.1471.9880.74
Long Term Debt269.53263.67251.00250.34249.44224.50
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities2.142.092.101.141.111.67
Total Liabilities343.28330.32336.25333.62322.53306.91
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity15.5921.6114.7823.5516.3622.76
Total Shareholders Equity15.5921.6114.7823.5516.3622.76
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity15.5921.6114.7823.5516.3622.76
Total Liabilities & Stockholders Equity358.88351.93351.04357.17338.89329.67
Book Value Per Share0.520.730.500.800.560.79
Tangible Book Value Per Share0.170.370.160.430.160.36
Full-Time Employees---1,004--
Price to Book Ratio128.56170.5770.66129.4152.1732.03
Return on Assets-11.02-11.41-12.78-14.51-26.70-28.80
Return on Equity-240.66-175.30-164.01-133.25-338.19-261.18
Return on Invested Capital-3.76-4.12-5.03-0.95-4.19-6.71
Quick Ratio2.382.521.912.002.101.66
Current Ratio3.573.842.963.043.332.84

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-10.97-12.46-13.38-3.01-11.22-16.55
Depreciation2.742.822.692.852.552.59
Other Funds (Non Cash)10.569.635.315.145.11-0.76
Funds from Operations2.32-0.01-5.38-4.22-3.56-14.71
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital5.60-17.181.073.67-7.77-3.99
Cash from Operating Activities7.93-17.19-4.31-0.56-11.33-18.70
Capital Expenditures-2.69-3.81-1.96-1.71-1.97-2.07
Net Assets From Acquisitions0.000.000.00-0.00-0.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-2.69-3.81-1.96-1.72-1.97-2.07
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.6116.401.017.270.030.27
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.6116.401.017.270.030.27
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.538.00-1.17-0.7629.534.99
Change in Long Term Debt-0.018.870.000.1924.510.00
Issuance of Long Term Debt-0.28272.460.000.1924.510.00
Reduction of Long Term Debt0.27-263.590.000.000.000.00
Net Financing Active Other Cash Flow-0.20-0.30-0.70-0.14-0.08-0.14
Other Financing Activities Uses-0.20-0.30-0.70-0.14-0.08-0.14
Cash from Financing Activities-0.1324.10-0.866.3729.485.12
Exchange Rate Effect-0.33-0.17-0.340.74-0.261.15
Net Change in Cash4.792.93-7.474.8415.93-14.50
Free Cash Flow7.03-21.00-6.16-2.43-13.18-20.33

Revenue breakdown

Orthopedic, Prosthetic & Surgical Appliances & Supplies2024: 166.03M 2025: 211.08M
Asia Pacific2024: 48.41M 2025: 34.54M
EMEA2024: 78.21M 2025: 91.05M
Latin America2024: 35.00M 2025: 39.93M
North America2024: 4.41M 2025: 45.56M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3014.35%3.9M27.3M456.24K
2026-10-1514.71%4.0M27.3M432.60K
2026-09-3014.55%4.0M27.4M451.96K
2026-09-1516.03%4.4M27.4M572.35K
2026-08-3116.10%4.4M27.3M604.40K
2026-08-1415.00%4.1M27.3M615.56K
2026-07-3116.13%4.3M27.0M608.93K
2026-07-1516.67%4.5M26.9M613.51K
2026-06-3017.72%4.8M26.9M585.25K
2026-06-1514.44%3.9M26.9M501.82K
2026-05-2914.21%3.8M26.9M492.65K
2026-05-1513.59%3.7M26.9M529.72K
2026-04-3014.13%3.8M26.7M496.37K
2026-04-1517.30%4.6M26.5M507.20K
2026-03-3119.71%5.2M26.5M526.48K
2026-03-1315.95%4.2M26.5M508.17K
2026-02-2715.82%4.2M26.5M481.49K
2026-02-1315.94%4.2M26.2M465.60K
2026-01-3015.65%4.1M26.2M537.01K
2026-01-1517.27%4.5M26.2M514.17K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call30.0039.4042.200.004.2530.000.000.995-0.0260.002
call32.5036.5040.100.004.1790.000.000.994-0.0260.002
call35.0034.0037.400.003.7080.000.000.993-0.0260.002
call37.5031.5035.100.003.5340.000.000.993-0.0260.002
call40.0029.0032.200.002.9990.000.000.992-0.0260.002
call42.5026.7029.7038.602.7411.000.000.991-0.0260.003
call45.0024.0027.3036.302.5531.000.000.990-0.0260.003
call47.5021.5024.9034.002.3671.000.000.982-0.0400.005
call50.0019.0022.3010.802.0914.000.000.911-0.1870.018
call52.5016.6019.800.001.8730.000.000.902-0.1810.019
call55.0014.1017.409.601.7032.000.000.853-0.2560.026
call57.5011.9015.100.001.5800.000.000.835-0.2430.028
call60.009.1012.306.501.26712.000.000.813-0.2280.030
call62.506.809.904.951.10635.000.000.785-0.2100.033
call65.004.708.004.801.05638.000.000.744-0.1920.036
call67.503.105.801.520.90111.000.000.657-0.2150.041
call70.001.354.002.190.80723.000.000.564-0.1830.044
call72.500.102.401.140.7032550.000.449-0.1930.044
call75.000.203.100.680.9096710.000.374-0.2180.042
call77.500.051.001.700.7163820.000.232-0.1380.034
call80.000.050.800.170.76651.000.000.181-0.1260.030
call82.500.002.2516.750.9145.000.000.160-0.1380.027
call85.000.002.207.651.0235030.000.146-0.1460.026
call87.500.002.151.051.1392.000.000.135-0.1530.024
call90.000.002.150.151.24076.000.000.127-0.1590.023
call92.500.002.150.001.3350.000.000.120-0.1650.022
call95.000.002.157.951.4121110.000.114-0.1690.022
call97.500.002.1511.551.5022.000.000.109-0.1740.021
call1000.002.150.151.5855090.000.105-0.1780.020
call1050.002.150.001.7430.000.000.097-0.1860.019
call1100.002.157.101.8871.000.000.092-0.1930.018
call1150.002.150.002.0350.000.000.087-0.1990.018
call1200.002.154.602.1631.000.000.083-0.2040.017
call1250.002.154.102.2842.000.000.080-0.2090.016
call1300.002.152.602.3981.000.000.077-0.2130.016
call1350.002.152.002.4962.000.000.074-0.2180.016
call1400.002.151.902.6102.000.000.072-0.2210.015
put30.000.002.150.002.3110.000.00-0.005-0.0220.002
put32.500.002.151.502.1101.000.00-0.006-0.0220.002
put35.000.002.151.251.9242.000.00-0.007-0.0220.002
put37.500.002.150.001.7560.000.00-0.007-0.0210.002
put40.000.002.151.451.5931.000.00-0.008-0.0210.002
put42.500.002.150.471.4365.000.00-0.009-0.0210.003
put45.000.000.050.001.1200.000.00-0.011-0.0180.003
put47.500.000.100.602.2278.000.00-0.128-0.2600.023
put50.000.002.150.051.8475.000.00-0.088-0.1820.018
put52.500.000.950.851.6431.000.00-0.098-0.1750.019
put55.000.002.301.291.7709830.00-0.147-0.2490.026
put57.500.002.351.041.5570.000.00-0.164-0.2360.028
put60.000.002.300.351.3442,4300.00-0.187-0.2210.030
put62.500.052.252.001.1382890.00-0.215-0.2030.033
put65.000.051.704.400.9315040.00-0.256-0.1850.036
put67.500.353.407.920.9378.000.00-0.343-0.2070.041
put70.000.852.604.900.6823.000.00-0.436-0.1750.044
put72.502.604.900.000.9020.000.00-0.549-0.1850.044
put75.004.006.800.000.9690.000.00-0.626-0.2100.042
put77.505.909.008.101.0761.000.00-0.767-0.1300.034
put80.008.4011.3015.201.1841.000.00-0.821-0.1190.029
put82.5010.5013.500.001.2540.000.00-0.840-0.1280.027
put85.0012.9016.0021.101.3761.000.00-0.854-0.1360.026
put87.5015.5018.500.001.5090.000.00-0.864-0.1430.024
put90.0017.7021.200.001.6770.000.00-0.873-0.1490.023
put92.5020.5023.5018.001.7355.000.00-0.880-0.1540.022
put95.0022.4026.200.001.8940.000.00-0.886-0.1590.021
put97.5024.9028.700.001.9950.000.00-0.891-0.1640.021
put10027.5031.200.002.0920.000.00-0.895-0.1680.020
put10532.4036.000.002.2150.000.00-0.902-0.1750.019
put11037.3041.000.002.3810.000.00-0.908-0.1810.018
put11542.6046.000.002.5370.000.00-0.913-0.1860.018
put12048.0051.000.002.6820.000.00-0.917-0.1910.017
put12552.3056.200.002.8970.000.00-0.920-0.1950.017
put13057.2061.000.002.9490.000.00-0.923-0.1990.016
put13562.5066.000.003.0720.000.00-0.926-0.2030.016
put14067.3071.000.003.1890.000.00-0.928-0.2060.015

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-158-KCurrent report2026-10-14SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-31SCHEDULE 13GSEC
2026-07-28SCHEDULE 13GSEC
2026-07-104Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014/A2026-06-24SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-293Initial statement of beneficial ownership of securities2026-06-24SEC
2026-06-298-KCurrent report2026-06-29SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-22SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-22SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-22SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-22SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050025.87M9
2026-04007.37M4
2026-03002.26M2
2026-020000
2026-010000
2025-120000
2025-11001.39M3

Institutional holders

Manager% owned
RTW INVESTMENTS, LP9.02%
JW Asset Management, LLC8.22%
BlackRock, Inc.5.38%
PRICE T ROWE ASSOCIATES INC /MD/5.21%
BROWN ADVISORY INC4.46%
FINDELL CAPITAL MANAGEMENT LLC3.72%
Mudita Advisors LLP2.46%
Rubric Capital Management LP2.34%
Nantahala Capital Management, LLC2.28%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2.24%

Funds

Fund% owned
iShares Russell 2000 ETF2.38%
T. Rowe Price New Horizons Fund, Inc.1.66%
Loomis Sayles Small Cap Growth Fund1.57%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund1.32%
Putnam Small Cap Growth Fund1.29%
Fidelity Small Cap Index Fund1.01%
iShares Russell 2000 Growth ETF0.86%
William Blair Small Cap Growth Fund0.84%
SmallCap Growth Fund I0.74%
Brown Advisory Small-Cap Growth Fund0.73%

OakChart. ESTA. Cached 15 minutes.